Related Experiment Videos
Lamotrigine drug interactions in a TDM material
Y Böttiger1, J O Svensson, L Ståhle
1Department of Medical Laboratory Sciences and Technology, Karolinska Institute, Huddinge University Hospital, Sweden.
Therapeutic Drug Monitoring
|April 27, 1999
Summary
Therapeutic drug monitoring (TDM) of lamotrigine reveals significant concentration/dose variations. Concomitant antiepileptic drugs, like carbamazepine and phenytoin, alter lamotrigine levels, impacting treatment efficacy.
Area of Science:
- Pharmacology
- Clinical Pharmacy
- Neuroscience
Background:
- Lamotrigine is an antiepileptic drug requiring careful dosing.
- Drug interactions can significantly alter lamotrigine pharmacokinetics.
- Therapeutic drug monitoring (TDM) is crucial for optimizing lamotrigine therapy.
Purpose of the Study:
- To investigate the concentration/dose (C/D) relationship of lamotrigine.
- To assess the impact of concomitant antiepileptic drug (AED) use on lamotrigine levels.
- To evaluate the utility of TDM for lamotrigine therapy.
Main Methods:
- Analysis of 149 lamotrigine TDM samples from 104 adult patients.
- Measurement of steady-state trough serum concentrations using high-performance liquid chromatography (HPLC).
- Correlation of lamotrigine levels with monotherapy and polytherapy regimens.
Main Results:
- Monotherapy C/D ratio was 65 nmol/L/mg.
- Carbamazepine and phenytoin significantly decreased the C/D ratio (31 and 17 nmol/L/mg, respectively).
- Valproic acid significantly increased the C/D ratio to 251 nmol/L/mg.
Conclusions:
- Significant interindividual variation in lamotrigine C/D ratios exists.
- Pharmacokinetic interactions with co-administered AEDs are the primary drivers of this variation.
- TDM is essential for personalized lamotrigine dosing and management.